Companisto

What they fund

Early-stage startups and growth companies seeking equity financing through collective investment [1]., Companies with strong innovation potential, often deep tech, AI, or health tech, with a focus on sustainability and scalability [1]., Rounds where Companisto can lead or co-lead, often with significant community participation (e.g., HERO's €40M Series B) [1]., Geographies primarily Germany and DACH, with some Swiss and international co-investors [1].

Investment thesis

Companisto operates as a digital investment network and fintech platform that democratizes startup investing, allowing private investors to collectively fund innovative, sustainable, and pioneering companies starting at €250 [1]. The platform emphasizes a "Pioneer Spirit" and quality control, vetting opportunities to ensure long-term value for both investors and founders [1]. It positions itself as a driver of professional online corporate financing, bridging the gap between retail investors and high-growth startups. The mission is to enable everyone to be an investor and help shape the future through collective venture capital investments [1].

Credibility: Companisto homepage and investment thesis page [1].

Value add

Companisto provides access to a large network of private investors, enhancing fundraising efficiency and community engagement for startups. It offers platform infrastructure for digital fundraising and investor management. Fit verdict: Ideal for startups seeking broad retail investor base and brand visibility alongside capital. Founder diligence script: 1. How does Companisto's investor network impact post-investment engagement? 2. What is the typical timeline for closing a round on the platform? 3. How does Companisto support portfolio companies post-funding? 4. What are the fees and terms for startups using the platform? 5. How does Companisto handle regulatory compliance for investors?

Portfolio focus

Deep Tech & AI: AMERIA AG (AI Made in Germany), IRUBIS (TU Munich BioTech), CrystalsFirst (AI drug discovery) [1]., Health Tech: DiaMonTech (non-invasive blood glucose measurement), Preventicus (health insurance scaling) [1]., Consumer & Scale-ups: HERO (craft sector, €40M Series B), FREDA (food scale-up from mymuesli co-founder) [1]., Sustainability & Energy: Nullpunkt AG (ice storage heat pump systems) [1].

Notable investments & exits

Doctena: Companisto investors exited via acquisition, though specific terms are not disclosed [1]., HERO: Secured €40M Series B in 2024, indicating successful follow-on funding [1]., DiaMonTech: Co-investment with Samsung, suggesting strategic exit or growth potential [1]., Several portfolio companies have reached significant revenue milestones, indicating successful scaling [1].

Strategic implications

Companisto's edge lies in its large, engaged retail investor network, which provides startups with both capital and market validation. The main risk is regulatory changes in crowdfunding and retail investing, which could impact platform operations. A signal of change would be a shift towards institutional co-investors or a new regulatory framework that favors traditional VC over platform-based funding.

Where they could go further

Expand into international markets beyond DACH to diversify risk and access larger investor pools., Develop more structured post-investment support for portfolio companies, such as mentorship or strategic partnerships., Enhance data analytics for investors to improve decision-making and platform transparency., Explore new asset classes or sectors, such as climate tech or Web3, to attract a broader range of startups and investors.